Eli Lilly's soaring stock price has sparked 2026 split speculation. Here's what a potential LLY split could mean and what investors should consider now.

Eli Lilly stock has soared in the triple digits over three years. Investors are excited about the company’s portfolio of weight loss drugs, which has generated blockbuster revenue. 10 stocks we like ...

Investors generally don't turn to pharmaceutical stocks with expectations of high growth in a short period of time. Instead, they scoop up these players for their promise of steady gains over the ...

Eli Lilly's share price now stands above $1,000. The company's outlook through the next few years seems strong. The pharma giant looks likely to conduct a stock split in the (relatively) near future.

The first week of February 2026 will be remembered as the day the pharmaceutical sector’s most famous partnership officially dissolved. For years, Eli Lilly and Company (NYSE: LLY) and Novo Nordisk ...

Meta Platforms generates high cash flow and can afford to take risks on AI spending. ASML's lithography machines are essential for manufacturing advanced AI chips. Eli Lilly isn't cheap, but its drug ...